Skip to main navigation Skip to search Skip to main content

Low risk of drug interactions when rolapitant is coadministered with CYP2D6 or BCRP substrates: integrated safety results

  • S Barbour
  • , X Wang
  • , A Poma
  • , M Aapro
  • , Jørn Herrstedt

Research output: Contribution to conference without publisher/journalPosterResearchpeer-review

Original languageEnglish
Publication date2015
Publication statusPublished - 2015
EventEuropean Cancer Congress (ECC) 2015 - Wien, Austria
Duration: 25. Sept 201529. Sept 2015

Conference

ConferenceEuropean Cancer Congress (ECC) 2015
Country/TerritoryAustria
CityWien
Period25/09/201529/09/2015

Cite this